nafronyl has been researched along with papaverine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Berger, PA; Hollister, LE; Tinklenberg, JR; Yesavage, JA | 1 |
| Hutten, H; Reichl, R; Vaupel, P | 1 |
| Baird, RN; Davies, AH; Horrocks, M; Magee, TR | 1 |
| Cooper, GG | 1 |
| Benazzo, M; Castelnuovo, P; Galioto, GB; Galioto, P; Mevio, E | 1 |
| Hollister, LE | 1 |
| Milanova, D; Nikolov, R; Nikolova, M | 1 |
| Cook, P; James, I | 1 |
1 review(s) available for nafronyl and papaverine
| Article | Year |
|---|---|
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Dementia; Hexobendine; Humans; Nafronyl; Papaverine; Vasodilator Agents | 1981 |
1 trial(s) available for nafronyl and papaverine
| Article | Year |
|---|---|
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Dementia; Hexobendine; Humans; Nafronyl; Papaverine; Vasodilator Agents | 1981 |
8 other study(ies) available for nafronyl and papaverine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Vasodilators in senile dementias: a review of the literature.
Topics: Aged; Cinnarizine; Cyclandelate; Dementia; Dihydroergotoxine; Drug Evaluation; Humans; Isoxsuprine; Mental Processes; Nafronyl; Papaverine; Pyrithioxin; Vasodilator Agents | 1979 |
Influence of various vasodilatory drugs on the cerebral circulation in rabbits and rats.
Topics: Animals; Bencyclane; Carotid Artery, Internal; Cerebrovascular Circulation; Cinnarizine; Injections, Intra-Arterial; Nafronyl; Papaverine; Pentoxifylline; Piribedil; Rabbits; Rats; Vascular Resistance; Vasodilator Agents; Vincamine; Xanthinol Niacinate | 1979 |
Praxilene (naftidrofuryl oxalate) as an alternative for the augmentation of femoro-distal bypass blood flow.
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Femoral Artery; Humans; Ischemia; Leg; Middle Aged; Monitoring, Intraoperative; Nafronyl; Papaverine; Saphenous Vein; Ultrasonography | 1992 |
Naftidrofluryl dose and vascular resistance.
Topics: Dose-Response Relationship, Drug; Femoral Artery; Humans; Injections, Intra-Arterial; Ischemia; Leg; Nafronyl; Papaverine; Popliteal Artery; Vascular Resistance | 1992 |
[A study using laser-Doppler velocimetry of modifications of the labyrinthine microcirculation induced by chemical and physical stimuli].
Topics: Animals; Cochlea; Lasers; Microcirculation; Nafronyl; Noise; Papaverine; Pentoxifylline; Phenylephrine; Pyrrolidines; Rabbits; Vasodilator Agents | 1989 |
Alzheimer's disease. Is it worth treating?
Topics: Aged; Alzheimer Disease; Dementia; Dihydroergotoxine; Humans; Nafronyl; Papaverine; Pentoxifylline; Piracetam; Procaine; Psychotropic Drugs | 1985 |
Study on the anti-hypoxic effect of cinnarizine and its interaction with prostacyclin.
Topics: Animals; Atmospheric Pressure; Brain; Cinnarizine; Drug Interactions; Epoprostenol; Hypoxia; Ischemia; Male; Mice; Nafronyl; Oxygen; Papaverine; Piperazines; Rats; Rats, Inbred Strains; Xanthinol Niacinate | 1984 |